West Pharmaceutical Services (WST)
(Real Time Quote from BATS)
$297.34 USD
-2.46 (-0.82%)
Updated Oct 2, 2024 09:48 AM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
WST 297.34 -2.46(-0.82%)
Will WST be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
West Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 View
West Pharmaceutical Services (WST) Q2 Earnings and Revenues Miss Estimates
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
4 Stocks to Buy Amid Dental Supplies Industry Challenges
Other News for WST
West Pharmaceutical Services Inc (WST) Shares Down 3.55% on Sep 30
High-Quality Dividend Stock Universe: Accenture Is Capitalizing On AI, But Currently Expensive
Tracking Ron Baron's BAMCO Portfolio - Q2 2024 Update
YieldBoost West Pharmaceutical Services From 0.3% To 8.8% Using Options
West Pharmaceutical Services Inc (WST) Trading 4.25% Higher on Sep 18